II Robert C. Goeltz

Chief Financial Officer, Arcus Biosciences, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.8M

Companies

Latest trade

May 11, 2026

Companies

Arcus Biosciences, Inc.Chief Financial Officer −$0.9M

Trades

RCUS Sold 7,763 shares at $25.63 · planned $0.2M May 11

RCUS Sold 6,552 shares at $23.38 · planned $0.2M Dec 31

RCUS Sold 5,960 shares at $22.16 · planned $0.1M Dec 17

RCUS Sold 6,702 shares at $21.88 · planned $0.1M Dec 16

RCUS Sold 5,000 shares at $25.00 · planned $0.1M Nov 26

RCUS Sold 5,000 shares at $20.00 · planned $0.1M Oct 28

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.